Pharmacogenomics
A personalized approach to medicine
This visiongain report provides you with the
most comprehensive guide to personalized medicines, numerous multicolored
graphs and uniquely compiled tables containing industry facts and figures
- can you afford to be without it?.
Several companies are leading the
pharmacogenomics revolution, which promises to:
1. Optimize the efficacy of therapeutic
compounds
2. Minimize adverse drug reactions and
associated long-term costs
3. Enhance the cost effectiveness of
clinical trials
4. Facilitate drug discovery, development,
and approval
Despite the infancy of personalized
medicines, genotype-specific medications is no longer a fiction of the
future, but a reality of the present.
A prime example of the potential benefits
of applying genomic knowledge to clinical therapy is the selective use of
Herceptin drug in breast cancer patients with genotypes that confer
positive response to pharmacological therapy.
This report will answer 6 key questions
such as:
1. Which companies are leading the
personalized medicine revolution?
2. What R&D areas are set to show
considerable growth?
3. What are the benefits of investing in
pharmacogenomics?
4. Will a research focus on personalized
medicine lead to dramatic changes in clinical therapy? 5. How will a
pharmacogenomic approach improve the effectiveness of clinical therapy,
minimise adverse reactions and incurred costs from drug failures in
developmental phases? 6. What are the knock-on effects of the Human Genome
Project on current research?
Contains:
This report presents an extensive and
detailed guide to the development of personalized medicines with its
related research areas and technology that span the biotechnology,
diagnostics, bioinformatics, pharmacological and genomic markets.
With 150+ pages, full-colour graphs,
tables, case studies, cutting-edge research studies, clinical trials, key
industry figures and facts, company profiles, R&D areas, this report
provides an introduction to the principles of pharmacogenomics and a
detailed guide to personalized medicines that is set to show considerable
growth.
By drawing on detailed profiles of
companies leading the revolution, this report examines the wide range of
areas that are ultimately linked to the development of personalized
medicines and how they effect your business today.
Why you must buy this report:
· Identify the level of competition and
key players in the personalized medicines revolution · Insight into the
potential benefits of pharmacogenomic research · Forecast of emerging
R&D areas
· How to enhance clinical trials and
maximise product development potential Pricing
- PRICING -
Individual report pricing - single user
copies of this report are available for only US$1595. Allow your whole
company to have access to this information for only the price of 4 copies.
Company-wide License (CD Rom and .pdf for company intranet use) for only
US$6395.
Size: 150 pages
Format: CD ROM
View
pdf brochure
To order - click
here!
